Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: dizziness, lightheadedness major surgical or invasive procedure: cardiac catheterization history of present illness: 67 yo male, h/o cad s/p cabg in (lima to lad, svg to om, svg to pda), htn, dm, hyperlipidemia, presenting iwth chest pain, transferred for cathterization. he presented to the ed in with complaints of dizziness. he states that he had episodes of dizziness in the past few weeks; the first occurred while driving. he reports feelings of dizziness and palpitations accompanied by lightheadedness and diaphoresis. he denied cp/sob/syncope. this recurred on night prior to admission and was accompanied by a brief episode of syncope (lasting seconds; denies seizure activity, post ictal confusion, no loss of bowel or bladder function). this is different from angina he has had in the past (describes occasional chest pain relieved by nitro s/p cabg). he went to the ed where tnt was reportedly 0.47 and ekg showed "inferolateral" changes by report. he was given 600 mg plavix, lovenox 80 mg, 5 mg iv lopressor, asa, and ntg. he was transferred to to cathterization lab where stent was placed to one of his svg grafts (by verbal report; written report not yet available) . upon arrival to the floor, he was nauseous (had been given versed, anzemet, and atropine in lab for this) and had some oozing from his left groin. he stated he still felt nauseous and dizzy but denied cp/sob. past medical history: pmh: 1. cad, s/p cabg in with lima to lad, svg to om, svg to pda 2. chf, ef=40% 3. dm 2 4. htn 5. hypercholesterolemia 6. gerd 7. s/p appy, with hernia at incisional site 8. dvt in as complication of catheterization, s/p vascular procedure for this as per his report social history: lives with girlfriend; smokes ppd x 50+ years no early cad family history: no early cad physical exam: pe: vs: 96.3 158/73 63 20 96% 2l nc fs=172 gen: mild distress, pleasant male, sleepy, a&ox3 heent: perrl, op clear neck: no jvd appreciated, no bruits lungs: cta bilat from anterior exam cv: rrr, nl s1/s2, no m/r/g abd: soft, nt/nd; with surgical scar in rlq, small reducible hernia involving umbilicus extr: trace edema bilaterally; 2+ dp/pt pulses bilaterally and sensation intact to light touch groin: left groin with sheath in place, mild ooze and tenderness to palpation pertinent results: ekg: nsr 65, with ivcd/incomplete left bundle, left axis; twi in ii, iii; q's in iii, f 11:40pm potassium-4.6 11:40pm ck(cpk)-38 11:40pm plt count-228 07:14pm potassium-4.1 07:14pm wbc-10.3 rbc-4.97# hgb-13.5*# hct-38.7*# mcv-78* mch-27.1 mchc-34.8 rdw-15.9* 05:36pm glucose-143* cardiac catheterization: des placed to svg to pda; lima to lad and svg to om patent brief hospital course: 1. cad: s/p cabg in , now with chest pain, ekg changes, and positive cardiac enzymes. catheterization was performed, and des was placed in svg-pda graft. he remained chest pain free, and ekg was without changes. ce's trended down and remained normal. he was maintained on asa, plavix, lopressor, lisinopril. he was started on lipitor, but patient stated he does not wish to take this and will discuss with his cardiologist. he had a large groin hematoma with superficial bruising. this resolved, and he never had bruit or signs of neurovascular compromise. hematocrit remained stable. he was discharged, to follow up with his cardiologist. 2. wct: patient developed witnessed wct on his second hospital stay post cath, his sbp was in the 170s and good mentation at the time of the wct. he felt slight dizzy at the time of wct, but denied any chest pressure, sob, or palpitation. he was given lidocaine bolus and spontaneously converted back to sinus rhthym. he was started on lidocaine drip and transferred to the ccu for further management. ep recommended discontinuing lidocaine drip and starting sotalol po intially 80mg po bid, which was increased to 120mg po bid. he was scheduled for an echo to evaluate lv function which showed an estimated ef of 40%, with focal wall motion abnormalities. icd/pacemaker (atrial sensed/paced) was placed on , and he had no further episodes of ventricular tachycardia. he will follow up in device clinic in 1 week for check. he was discharged on the sotalol and metoprolol. 3. chf: tte was checked; ef was 40% with multiple wall motion abnormalities (no apical akinesis). acei was continued, and he remained euvolemic. 4. nausea/vomiting: s/p cath, may be vagal component (s/p atropine in cath lab). he was given antiemetics as needed, and this resolved. 5. dm: on glyburide and metformin as , cover with ssi in-house. oral hypoglycemics were restarted at time of discharge. 6. crf: creatinine remained stable (baseline 1.5-1.6). he received fluids with hco3- after catheterization/dye load. 7. htn: nitro gtt was continued after cath lab until sbp normalized. he was continued on bb and acei in-house. 8. uti: he was found to have a uti (leukocytosis, positive ua), and he was started on ciprofloxacin x 7 days. 9. disposition: he was discharged in good condition, to follow up in device clinic and with he cardiologist. medications on admission: meds on admission: metoprolol 50 mg metformin 1000 mg allopurinol 150 mg zantac 150 mg glyburide 5 mg lisinopril 10 mg qd all: nkda discharge medications: 1. aspirin 325 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily) as needed for pci. disp:*30 tablet, delayed release (e.c.)(s)* refills:*11* 2. clopidogrel 75 mg tablet sig: one (1) tablet po daily (daily) as needed for pci. disp:*30 tablet(s)* refills:*11* 3. allopurinol 100 mg tablet sig: 1.5 tablets po daily (daily). 4. atorvastatin 80 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 5. sotalol 80 mg tablet sig: 1.5 tablets po bid (2 times a day). disp:*90 tablet(s)* refills:*2* 6. lisinopril 20 mg tablet sig: one (1) tablet po daily (daily). 7. zantac 150 mg capsule sig: one (1) capsule po twice a day. 8. metformin 1,000 mg tablet sig: one (1) tablet po twice a day. 9. glyburide 5 mg tablet sig: one (1) tablet po twice a day. 10. metoprolol tartrate 50 mg tablet sig: one (1) tablet po bid (2 times a day). 11. ciprofloxacin 500 mg tablet sig: one (1) tablet po q12h (every 12 hours) for 6 days. disp:*12 tablet(s)* refills:*0* discharge disposition: home with service facility: nursing services discharge diagnosis: primary diagnoses: 1. cad, s/p catheterization and stenting 2. ventricular tachycardia, s/p placement of icd 3. hypertension secondary diagnoses: 1. diabetes mellitus, type 2 2. hyperlipidemia 3. renal insufficiency 4. urinary tract infection discharge condition: good discharge instructions: 1. weigh yourself every morning, md if weight > 3 lbs. adhere to 2 gm sodium diet fluid restriction: 1500 cc daily 2. please follow up with your cardiologist as described below. 3. please take all your medications exactly as prescribed and described in this discharge paperwork. we made the following changes: - asa 325 mg daily and plavix 75 mg daily for at least 1 year. it is extremely important that you take these medications every day, without missing a single dose. they will help prevent your new stent from clotting. - sotalol 80 mg twice daily - we added lipitor 80 mg daily. - we added ciprofloxacin 500 mg twice daily for 6 more days for your urinary tract infection. 4. please call your doctor if you are experiencing chest pain, shortness of breath, fever, chills, palpitations, lightheadedness, dizziness, or any other concerning symptoms. followup instructions: 1. follow up with dr. () within 1-2 weeks of discharge 2. follow up with ep as instructed at time of discharge. provider: clinic phone: date/time: 9:00 you must keep the dressing over your icd clean and dry until you follow up in clinic. 3. you should avoid heavy lifting or physical exertion for at least 2-3 weeks. adhere to driving restrictions outlined. 4. you will need monitoring of your liver function given lipitor therapy. this should be done at least every 6 months. procedure: insertion of non-drug-eluting coronary artery stent(s) coronary arteriography using two catheters left heart cardiac catheterization implantation or replacement of automatic cardioverter/defibrillator, total system [aicd] cranial or peripheral nerve graft insertion of one vascular stent excision of lingual thyroid percutaneous transluminal coronary angioplasty [ptca] procedure on single vessel diagnoses: subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery pure hypercholesterolemia urinary tract infection, site not specified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified coronary atherosclerosis of autologous vein bypass graft paroxysmal ventricular tachycardia 

Answer: The patient is high likely exposed to